annual EBITDA:
-$176.14M-$109.73M(-165.22%)Summary
- As of today (July 1, 2025), OCUL annual EBITDA is -$176.14 million, with the most recent change of -$109.73 million (-165.22%) on December 31, 2024.
- During the last 3 years, OCUL annual EBITDA has fallen by -$178.68 million (-7037.50%).
- OCUL annual EBITDA is now -7037.50% below its all-time high of $2.54 million, reached on December 31, 2021.
Performance
OCUL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$60.09M-$15.76M(-35.54%)Summary
- As of today (July 1, 2025), OCUL quarterly EBITDA is -$60.09 million, with the most recent change of -$15.76 million (-35.54%) on March 31, 2025.
- Over the past year, OCUL quarterly EBITDA has dropped by -$211.00 thousand (-0.35%).
- OCUL quarterly EBITDA is now -1203.34% below its all-time high of $5.45 million, reached on March 31, 2021.
Performance
OCUL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$176.35M-$211.00K(-0.12%)Summary
- As of today (July 1, 2025), OCUL TTM EBITDA is -$176.35 million, with the most recent change of -$211.00 thousand (-0.12%) on March 31, 2025.
- Over the past year, OCUL TTM EBITDA has dropped by -$78.13 million (-79.54%).
- OCUL TTM EBITDA is now -7043.07% below its all-time high of $2.54 million, reached on December 31, 2021.
Performance
OCUL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OCUL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -165.2% | -0.3% | -79.5% |
| 3 y3 years | -7037.5% | -483.3% | -1235.2% |
| 5 y5 years | -126.6% | -213.9% | -88.3% |
OCUL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7037.5% | at low | -1681.3% | at low | -650.1% | at low |
| 5 y | 5-year | -7037.5% | at low | -1203.3% | +27.8% | -7043.1% | at low |
| alltime | all time | -7037.5% | at low | -1203.3% | +27.8% | -7043.1% | at low |
OCUL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$60.09M(+35.5%) | -$176.35M(+0.1%) |
| Dec 2024 | -$176.14M(+165.2%) | -$44.33M(+37.2%) | -$176.14M(+13.0%) |
| Sep 2024 | - | -$32.31M(-18.5%) | -$155.92M(+30.1%) |
| Jun 2024 | - | -$39.63M(-33.8%) | -$119.81M(+22.0%) |
| Mar 2024 | - | -$59.88M(+148.3%) | -$98.23M(+47.9%) |
| Dec 2023 | -$66.42M(+7.3%) | -$24.11M(-734.5%) | -$66.42M(+19.6%) |
| Sep 2023 | - | $3.80M(-121.1%) | -$55.51M(-31.6%) |
| Jun 2023 | - | -$18.04M(-35.7%) | -$81.19M(+1.9%) |
| Mar 2023 | - | -$28.07M(+112.6%) | -$79.67M(+28.7%) |
| Dec 2022 | -$61.91M(-2538.2%) | -$13.20M(-39.7%) | -$61.91M(+23.1%) |
| Sep 2022 | - | -$21.88M(+32.5%) | -$50.30M(+114.0%) |
| Jun 2022 | - | -$16.52M(+60.3%) | -$23.51M(+78.0%) |
| Mar 2022 | - | -$10.30M(+543.9%) | -$13.21M(-620.0%) |
| Dec 2021 | $2.54M(-101.7%) | -$1.60M(-132.6%) | $2.54M(-103.2%) |
| Sep 2021 | - | $4.91M(-179.0%) | -$79.08M(-15.5%) |
| Jun 2021 | - | -$6.21M(-214.1%) | -$93.55M(-23.0%) |
| Mar 2021 | - | $5.45M(-106.5%) | -$121.50M(-16.8%) |
| Dec 2020 | -$146.09M(+87.9%) | -$83.22M(+770.1%) | -$146.09M(+69.1%) |
| Sep 2020 | - | -$9.56M(-72.0%) | -$86.41M(-7.7%) |
| Jun 2020 | - | -$34.17M(+78.5%) | -$93.64M(+14.8%) |
| Mar 2020 | - | -$19.14M(-18.7%) | -$81.56M(+4.9%) |
| Dec 2019 | -$77.74M(+38.9%) | -$23.54M(+40.2%) | -$77.74M(+10.0%) |
| Sep 2019 | - | -$16.79M(-24.0%) | -$70.65M(+4.1%) |
| Jun 2019 | - | -$22.09M(+44.1%) | -$67.87M(+15.9%) |
| Mar 2019 | - | -$15.33M(-6.8%) | -$58.57M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$55.95M(-6.5%) | -$16.44M(+17.3%) | -$55.95M(+8.4%) |
| Sep 2018 | - | -$14.01M(+9.6%) | -$51.59M(-1.1%) |
| Jun 2018 | - | -$12.78M(+0.5%) | -$52.17M(-8.9%) |
| Mar 2018 | - | -$12.71M(+5.2%) | -$57.26M(-4.4%) |
| Dec 2017 | -$59.87M(+42.1%) | -$12.08M(-17.2%) | -$59.87M(-0.1%) |
| Sep 2017 | - | -$14.59M(-18.3%) | -$59.94M(+10.4%) |
| Jun 2017 | - | -$17.87M(+16.7%) | -$54.30M(+14.9%) |
| Mar 2017 | - | -$15.32M(+26.1%) | -$47.24M(+12.1%) |
| Dec 2016 | -$42.14M(+13.1%) | -$12.15M(+35.7%) | -$42.14M(+5.3%) |
| Sep 2016 | - | -$8.95M(-17.2%) | -$40.02M(-4.7%) |
| Jun 2016 | - | -$10.82M(+5.9%) | -$41.99M(+3.5%) |
| Mar 2016 | - | -$10.22M(+1.9%) | -$40.59M(+8.9%) |
| Dec 2015 | -$37.27M(+38.1%) | -$10.03M(-8.2%) | -$37.27M(+7.6%) |
| Sep 2015 | - | -$10.92M(+16.0%) | -$34.62M(+13.7%) |
| Jun 2015 | - | -$9.42M(+36.5%) | -$30.44M(+12.7%) |
| Mar 2015 | - | -$6.90M(-6.5%) | -$27.01M(+0.1%) |
| Dec 2014 | -$26.98M(+116.3%) | -$7.38M(+9.5%) | -$26.98M(+17.9%) |
| Sep 2014 | - | -$6.74M(+12.7%) | -$22.89M(+17.5%) |
| Jun 2014 | - | -$5.98M(-12.9%) | -$19.48M(+18.9%) |
| Mar 2014 | - | -$6.87M(+108.9%) | -$16.39M(+31.4%) |
| Dec 2013 | -$12.47M(-6.3%) | -$3.29M(-1.4%) | -$12.47M(+35.8%) |
| Sep 2013 | - | -$3.34M(+15.5%) | -$9.18M(+57.1%) |
| Jun 2013 | - | -$2.89M(-2.3%) | -$5.85M(+97.7%) |
| Mar 2013 | - | -$2.96M | -$2.96M |
| Dec 2012 | -$13.31M | - | - |
FAQ
- What is Ocular Therapeutix annual EBITDA?
- What is the all time high annual EBITDA for Ocular Therapeutix?
- What is Ocular Therapeutix annual EBITDA year-on-year change?
- What is Ocular Therapeutix quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly EBITDA year-on-year change?
- What is Ocular Therapeutix TTM EBITDA?
- What is the all time high TTM EBITDA for Ocular Therapeutix?
- What is Ocular Therapeutix TTM EBITDA year-on-year change?
What is Ocular Therapeutix annual EBITDA?
The current annual EBITDA of OCUL is -$176.14M
What is the all time high annual EBITDA for Ocular Therapeutix?
Ocular Therapeutix all-time high annual EBITDA is $2.54M
What is Ocular Therapeutix annual EBITDA year-on-year change?
Over the past year, OCUL annual EBITDA has changed by -$109.73M (-165.22%)
What is Ocular Therapeutix quarterly EBITDA?
The current quarterly EBITDA of OCUL is -$60.09M
What is the all time high quarterly EBITDA for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly EBITDA is $5.45M
What is Ocular Therapeutix quarterly EBITDA year-on-year change?
Over the past year, OCUL quarterly EBITDA has changed by -$211.00K (-0.35%)
What is Ocular Therapeutix TTM EBITDA?
The current TTM EBITDA of OCUL is -$176.35M
What is the all time high TTM EBITDA for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM EBITDA is $2.54M
What is Ocular Therapeutix TTM EBITDA year-on-year change?
Over the past year, OCUL TTM EBITDA has changed by -$78.13M (-79.54%)